Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
Brisbane scientists have found that eating a high-fat diet over a long period-of-time may induce early Barrett’s oesophagus, a precursor condition to oesophageal cancer. TRI awarded a 2015...Read more
TRI researchers have received vital funding from the Australian Government to trial a new diagnostic for epithelial ovarian cancer (EOC), the first study of its kind in humans. Mater Research...Read more
A new research grant will help researchers better understand and potentially treat prostate cancer, which has spread to the bones. Cure Cancer Australian, Cancer Australia and the Can Too Foundation...Read more
An arsenal of proteins used by many cell types to communicate with and control other cells could hold the answers to treating a multitude of diseases, especially cancer. The University of Queensland...Read more
QUT biomedical scientists affiliated with TRI have developed a simple saliva test, which has detected early throat cancer in a person who had no symptoms and no clinical signs of cancer. In what is...Read more
Australian scientists are ready to trial a new ‘precision-medicine’ agent designed to deliver imaging agents and anti-cancer drugs to ovarian and pancreatic cancers in patients with...Read more
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more
University of Queensland (UQ) researchers based at TRI are unlocking the secrets of melanoma cells to identify potential new drug targets and personalised treatment regimens for patients with the...Read more
Scientists from Mater Research – The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows...Read more
Mater researchers based at TRI have partnered with QUT’s Institute of Health and Biomedical Innovation (IHBI) to establish a unique breast cancer biobank to better support Queensland...Read more